137 related articles for article (PubMed ID: 26205378)
1. A Small-Molecule Probe for Selective Profiling and Imaging of Monoamine Oxidase B Activities in Models of Parkinson's Disease.
Li L; Zhang CW; Ge J; Qian L; Chai BH; Zhu Q; Lee JS; Lim KL; Yao SQ
Angew Chem Int Ed Engl; 2015 Sep; 54(37):10821-5. PubMed ID: 26205378
[TBL] [Abstract][Full Text] [Related]
2. A sensitive two-photon probe to selectively detect monoamine oxidase B activity in Parkinson's disease models.
Li L; Zhang CW; Chen GY; Zhu B; Chai C; Xu QH; Tan EK; Zhu Q; Lim KL; Yao SQ
Nat Commun; 2014; 5():3276. PubMed ID: 24522637
[TBL] [Abstract][Full Text] [Related]
3. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740
[TBL] [Abstract][Full Text] [Related]
4. Oxazolopyridines and thiazolopyridines as monoamine oxidase B inhibitors for the treatment of Parkinson's disease.
Park HR; Kim J; Kim T; Jo S; Yeom M; Moon B; Choo IH; Lee J; Lim EJ; Park KD; Min SJ; Nam G; Keum G; Lee CJ; Choo H
Bioorg Med Chem; 2013 Sep; 21(17):5480-7. PubMed ID: 23810676
[TBL] [Abstract][Full Text] [Related]
5. 1-[2-(4-Benzyloxyphenoxy)Ethyl]Imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson's disease.
Chung JY; Lee JW; Ryu CH; Min HK; Yoon YJ; Lim MJ; Park CH
J Neurosci Res; 2015 Aug; 93(8):1267-78. PubMed ID: 25711470
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.
Legoabe LJ; Petzer A; Petzer JP
Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913
[TBL] [Abstract][Full Text] [Related]
7. Novel MAO-B inhibitors: potential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson's disease.
Unzeta M; Sanz E
Int Rev Neurobiol; 2011; 100():217-36. PubMed ID: 21971010
[TBL] [Abstract][Full Text] [Related]
8. [Neurochemical perspectives of the function of monoamine oxidases].
Riederer P; Konradi C; Hebenstreit G
Psychiatr Prax; 1989 Aug; 16 Suppl 1():7-10. PubMed ID: 2685857
[TBL] [Abstract][Full Text] [Related]
9. A Strategy for Specific Fluorescence Imaging of Monoamine Oxidase A in Living Cells.
Wu X; Shi W; Li X; Ma H
Angew Chem Int Ed Engl; 2017 Nov; 56(48):15319-15323. PubMed ID: 29027345
[TBL] [Abstract][Full Text] [Related]
10. Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques.
Rojas RJ; Edmondson DE; Almos T; Scott R; Massari ME
Bioorg Med Chem; 2015 Feb; 23(4):770-8. PubMed ID: 25600407
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of monoamine oxidase by indole and benzofuran derivatives.
Prins LH; Petzer JP; Malan SF
Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099
[TBL] [Abstract][Full Text] [Related]
12. Selected chromone derivatives as inhibitors of monoamine oxidase.
Legoabe LJ; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2012 Sep; 22(17):5480-4. PubMed ID: 22850212
[TBL] [Abstract][Full Text] [Related]
13. Elucidating the mechanism of action and potential interactions of MAO-B inhibitors.
Bainbridge JL; Page RL; Ruscin JM
Neurol Clin; 2008 Aug; 26(3 Suppl):S85-96, vi. PubMed ID: 18774444
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory monoamine oxidases of the new generation].
Nowakowska E; Chodera A
Pol Merkur Lekarski; 1997 Jul; 3(13):1-4. PubMed ID: 9432289
[TBL] [Abstract][Full Text] [Related]
15. Sensitive and Selective Ratiometric Fluorescence Probes for Detection of Intracellular Endogenous Monoamine Oxidase A.
Wu X; Li L; Shi W; Gong Q; Li X; Ma H
Anal Chem; 2016 Jan; 88(2):1440-6. PubMed ID: 26652905
[TBL] [Abstract][Full Text] [Related]
16. Association of a monoamine oxidase B allele with Parkinson's disease.
Kurth JH; Kurth MC; Poduslo SE; Schwankhaus JD
Ann Neurol; 1993 Apr; 33(4):368-72. PubMed ID: 8489207
[TBL] [Abstract][Full Text] [Related]
17. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846
[TBL] [Abstract][Full Text] [Related]
18. Monoamine oxidase B activatable red fluorescence probe for bioimaging in cells and zebrafish.
Yang Z; Zhong T; Mo Q; He J; Chong J; Hu X; Zhao S; Qin J
Bioorg Chem; 2024 Apr; 145():107156. PubMed ID: 38387393
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial-Targeted and Near-Infrared Fluorescence Probe for Bioimaging and Evaluating Monoamine Oxidase A Activity in Hepatic Fibrosis.
Yang ZM; Mo QY; He JM; Mo DL; Li J; Chen H; Zhao SL; Qin JK
ACS Sens; 2020 Apr; 5(4):943-951. PubMed ID: 32223138
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging.
Bar-Am O; Amit T; Kupershmidt L; Aluf Y; Mechlovich D; Kabha H; Danovitch L; Zurawski VR; Youdim MB; Weinreb O
Neurobiol Aging; 2015 Mar; 36(3):1529-42. PubMed ID: 25499799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
